Eloxx Pharmaceuticals CEO Bob Ward is cognizant that one day, emerging science could usurp his company's approach to treating genetic diseases.
While many biotechs are testing more experimental means of treating some of the 1,800 genetic diseases that impair the body's ability to produce...